Mauna Kea Technologies (Mauna Kea Technologies) Total Liabilities : $43.85 Mil (As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Mauna Kea Technologies Total Liabilities?

Mauna Kea Technologies's Total Liabilities for the quarter that ended in Dec. 2023 was $43.85 Mil.

Mauna Kea Technologies's quarterly Total Liabilities increased from Dec. 2022 ($42.07 Mil) to Jun. 2023 ($44.00 Mil) but then declined from Jun. 2023 ($44.00 Mil) to Dec. 2023 ($43.85 Mil).

Mauna Kea Technologies's annual Total Liabilities increased from Dec. 2021 ($39.64 Mil) to Dec. 2022 ($42.07 Mil) and increased from Dec. 2022 ($42.07 Mil) to Dec. 2023 ($43.85 Mil).

Mauna Kea Technologies Total Liabilities Historical Data

The historical data trend for Mauna Kea Technologies's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mauna Kea Technologies Total Liabilities Chart

Mauna Kea Technologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

25.96

39.76

39.64

42.07

43.85

Mauna Kea Technologies Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Liabilities	Get a 7-Day Free Trial															39.64	34.87	42.07	44.00	43.85

Mauna Kea Technologies Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Mauna Kea Technologies's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	29.16	+	(14.614	+	0.079999999999998
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	43.85

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	25.014	-	-18.84
	=	43.85

Mauna Kea Technologies's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	29.16	+	(14.614	+	0.079999999999998
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	43.85

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	25.014	-	-18.84
	=	43.85

Mauna Kea Technologies Total Liabilities Related Terms

Thank you for viewing the detailed overview of Mauna Kea Technologies's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Mauna Kea Technologies (Mauna Kea Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Mauna Kea Technologies SA (OTCPK:MKEAF) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

ALMKT:France 1MK:Germany

Address

9, rue d'Enghien, Paris, FRA, 75010

Website

https://www.maunakeatech.com

Mauna Kea Technologies SA is a medical device corporation. It is engaged in designing, developing, and marketing an imaging platform used to view tissues at a cellular level, in real-time, during standard procedures. The firm operates in the business segment of Endomicroscopy. The group's technological platform is Cellvizio which helps physicians to detect early-stage pathologies more accurately and make therapeutic decisions. It generates revenue from the sales of Cellvizio products and accessories used for medical diagnostics, research, and related services. The company sells its products in France and internationally, of which the majority of the revenue is derived from America.

Mauna Kea Technologies (Mauna Kea Technologies) Headlines

From GuruFocus

Q1 2022 Mauna Kea Technologies SAS Earnings Call Transcript

By GuruFocus Research • 03-01-2024

Q4 2020 Mauna Kea Technologies SAS Earnings and Q1 2021 Sales Release Transcript

By GuruFocus Research • 03-01-2024